Plain-English translation of NCT07154719 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing how , a medication used to treat obesity and type 2 diabetes, affects your muscles and bones as you lose weight. Doctors know that helps people lose weight, but they want to understand whether this weight loss includes unhealthy loss of muscle and bone. This study will help answer that important question.
Recent reports have raised concerns that when people lose weight using this medication, they may be losing too much muscle along with fat, which could lead to weakness and bone problems. This trial exists to carefully measure what's actually happening to muscles and bones during weight loss treatment, so doctors can better understand the full health effects.
You will take for 5 months while the research team monitors your muscle and bone health through scans and tests. Depending on which group you're in, you'll either receive a lifestyle toolkit with nutrition and exercise guidance, or follow your regular diet and exercise routine. You'll have multiple visits to the research center for medical exams, blood tests, and body composition scans (like a special X-ray that measures muscle and bone).
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States